Tech Company Financing Transactions
ARYx Therapeutics Funding Round
Ascent Venture Partners, Merlin BioMed Group and Montreux Equity Partners invested in a $30.4 million funding round for ARYx Therapeutics. The funding round closed on 3/22/2007.
Transaction Overview
Company Name
Announced On
3/22/2007
Transaction Type
Venture Equity
Amount
$30,399,700
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
6300 Dumbarton Cir.
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Overview
ARYx Therapeutics is a privately-held, product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Goddard
Chief Operating Officer
John Varian
Chief Scientific Officer
Pascal Druzgala
Browse more venture capital transactions:
Prev: 3/21/2007: Artimi venture capital transaction
Next: 3/22/2007: Quantance venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs